99 related articles for article (PubMed ID: 11725479)
1. [Effect of hormone replacement therapy including a progestin on insulin sensitivity and lipid profile in postmenopausal women].
Grover-Páez F; Martínez-Abundis E; González-Ortiz M
Rev Med Chil; 2001 Sep; 129(9):989-94. PubMed ID: 11725479
[TBL] [Abstract][Full Text] [Related]
2. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
[TBL] [Abstract][Full Text] [Related]
3. Three-year study of estrogen alone versus combined with progestin in postmenopausal women with or without hypercholesterolemia.
Sanada M; Nakagawa H; Kodama I; Sakasita T; Ohama K
Metabolism; 2000 Jun; 49(6):784-9. PubMed ID: 10877207
[TBL] [Abstract][Full Text] [Related]
4. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.
Araújo DA; Farias ML; Andrade AT
Climacteric; 2002 Sep; 5(3):286-92. PubMed ID: 12419087
[TBL] [Abstract][Full Text] [Related]
5. The hypoglycemic effects of soy isoflavones on postmenopausal women.
Cheng SY; Shaw NS; Tsai KS; Chen CY
J Womens Health (Larchmt); 2004 Dec; 13(10):1080-6. PubMed ID: 15650341
[TBL] [Abstract][Full Text] [Related]
6. Insulin sensitivity during postmenopausal hormone replacement with transdermal estradiol and intrauterine levonorgestrel.
Raudaskoski T; Tomás C; Laatikainen T
Acta Obstet Gynecol Scand; 1999 Jul; 78(6):540-5. PubMed ID: 10376866
[TBL] [Abstract][Full Text] [Related]
7. The effects of estrogen therapy and estrogen combined with different androgenic progestins on carbohydrate and lipid metabolism in overweight-obese younger postmenopausal women.
Demir B; Ozturkoglu E; Solaroglu A; Baskan B; Kandemir O; Karabulut E; Haberal A
Gynecol Endocrinol; 2008 Jun; 24(6):347-53. PubMed ID: 18584415
[TBL] [Abstract][Full Text] [Related]
8. Effect of different preparations of hormone therapy on lipid and glucose metabolism, coagulation factors, and bone mineral density in overweight and obese postmenopausal women.
Osmanağaoğlu MA; Osmanağaoğlu S; Osmanağaoğlu T; Okumuş B; Bozkaya H
Fertil Steril; 2005 Aug; 84(2):384-93. PubMed ID: 16084879
[TBL] [Abstract][Full Text] [Related]
9. Effects of treatment with testosterone alone or in combination with estrogen on insulin sensitivity in postmenopausal women.
Zang H; Carlström K; Arner P; Hirschberg AL
Fertil Steril; 2006 Jul; 86(1):136-44. PubMed ID: 16750207
[TBL] [Abstract][Full Text] [Related]
10. The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women.
Bayrak A; Aldemir DA; Bayrak T; Corakçi A; Dursun P
Arch Gynecol Obstet; 2006 Aug; 274(5):289-96. PubMed ID: 16810536
[TBL] [Abstract][Full Text] [Related]
11. Insulin resistance and hypertension in postmenopausal women.
Feldstein CA; Akopian M; Renauld A; Olivieri AO; Cauterucci S; Garrido D
J Hum Hypertens; 2002 Mar; 16 Suppl 1():S145-50. PubMed ID: 11986914
[TBL] [Abstract][Full Text] [Related]
12. [Influence of estrogen replacement therapy on atherogenic profile in postmenopausal women].
Alfonso Cano C; Vez García MD; García Urruticoechea P; Tornel Osorio PL; Canteras Jordana M; Abellán Alemán J
An Med Interna; 2003 Feb; 20(2):70-4. PubMed ID: 12703158
[TBL] [Abstract][Full Text] [Related]
13. Predictors of worsening insulin sensitivity in postmenopausal women.
Goodrow GJ; L'Hommedieu GD; Gannon B; Sites CK
Am J Obstet Gynecol; 2006 Feb; 194(2):355-61. PubMed ID: 16458629
[TBL] [Abstract][Full Text] [Related]
14. The effect of hormone replacement therapy on endothelial function in postmenopausal women with hypertension.
Czarnecka D; Kawecka-Jaszcz K; Olszanecka A; Dembińska-Kieć A; Malczewska-Malec M; Zdzienicka A; Guevara I
Med Sci Monit; 2004 Feb; 10(2):CR55-61. PubMed ID: 14737044
[TBL] [Abstract][Full Text] [Related]
15. Flow resistance in carotid and middle cerebral arteries in postmenopausal women: a comparative study of tibolone and continuous combined hormone replacement therapy.
Pan HA; Wang ST; Chen CH; Pai MC; Wu MH; Huang KE
Climacteric; 2002 Sep; 5(3):259-65. PubMed ID: 12419084
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Pueraria lobata with hormone replacement therapy in treating the adverse health consequences of menopause.
Woo J; Lau E; Ho SC; Cheng F; Chan C; Chan AS; Haines CJ; Chan TY; Li M; Sham A
Menopause; 2003; 10(4):352-61. PubMed ID: 12851519
[TBL] [Abstract][Full Text] [Related]
17. Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.
Christodoulakos G; Lambrinoudaki I; Panoulis C; Sioulas V; Rizos D; Caramalis G; Botsis D; Creatsas G
Maturitas; 2005 Apr; 50(4):321-30. PubMed ID: 15780533
[TBL] [Abstract][Full Text] [Related]
18. Plasma adiponectin levels in postmenopausal women with or without long-term hormone therapy.
Im JA; Lee JW; Lee HR; Lee DC
Maturitas; 2006 Apr; 54(1):65-71. PubMed ID: 16198517
[TBL] [Abstract][Full Text] [Related]
19. Vasoactive biomarkers and oxidative stress in healthy recently postmenopausal women treated with hormone replacement therapy.
Maffei S; Mercuri A; Prontera C; Zucchelli GC; Vassalle C
Climacteric; 2006 Dec; 9(6):452-8. PubMed ID: 17085378
[TBL] [Abstract][Full Text] [Related]
20. The effects of GH replacement therapy on cardiac morphology and function, exercise capacity and serum lipids in elderly patients with GH deficiency.
Elgzyri T; Castenfors J; Hägg E; Backman C; Thorén M; Bramnert M
Clin Endocrinol (Oxf); 2004 Jul; 61(1):113-22. PubMed ID: 15212653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
